These findings demonstrate that 5-HT-Htr2b signaling negatively regulates insulin sensitivity and energy metabolism in skeletal muscles, providing new insights into the role of peripheral serotonin in muscle metabolism and potential therapeutic targets for metabolic disorders. This evidence concerns the gene HTR5A and metabolic disease.